Clinical Trials Logo
  1. Home
  2. Platelet Aggregation Inhibitors
  3. NCT00325390

Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation

Platelet Aggregation Inhibitors Clinical Trial

Official title:
Double-Blind Parallel Comparison Study of SR25990C Versus Standard Therapy in Japan(Ticlopidine) in Patients With Acute Coronary Syndrome Without ST-Segment Elevation Who Are Planned for Percutaneous Coronary Intervention

Clinical Trial Summary

To evaluate the efficasy and safety of SR25990C(loading dose:300mg, maintenance dose:75mg/day) in comparison with the standard Japanese treatment(ticlopidine) in patients with acute coronary syndrome without ST-segment elevation and planned for percutaneous coronary intervention(including stenting).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00325390
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 3
Start date July 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT02554006 - Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings N/A
Recruiting NCT04796714 - AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE Phase 4
Completed NCT02711410 - The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients N/A
Completed NCT05278637 - GM03 - Platelet RNA Signatures of Aspirin Early Phase 1
Recruiting NCT03288441 - Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia
Recruiting NCT05306951 - Correct Timing of Head Imaging in Trauma
Recruiting NCT05732701 - Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions N/A
Recruiting NCT05702463 - Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II Phase 1
Not yet recruiting NCT03862651 - Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE) Phase 2
Completed NCT01354808 - ACCEL-LOADING-ACS Study Phase 4
Completed NCT00799396 - Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study) Phase 4
Completed NCT04999293 - Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention
Completed NCT04328883 - Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin Phase 1
Completed NCT02808767 - Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction Phase 4
Completed NCT00769938 - WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) Phase 4
Completed NCT03599284 - The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel Phase 2
Completed NCT03785509 - The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients
Unknown status NCT01103843 - Plavix, Prasugrel and Drug Eluting Stents Pilot Trial N/A
Active, not recruiting NCT03462498 - ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS Phase 4